Email this article 
Allergicheskiy kon\"yunktivit:sovremennyy vzglyad na aktual'nuyuproblemu
- Authors: Kurbacheva O.M.1, Pavlova KS1
-
Affiliations:
- Issue: Vol 8, No 1 (2011)
- Pages: 82-87
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.03.2011
- URL: https://rusalljournal.ru/raj/article/view/821
- DOI: https://doi.org/10.36691/RJA821
- ID: 821
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
В статье рассмотрены вопросы определения и классификации аллергического конъюнктивита,
особенности действия антигистаминных препаратов местного действия, в том числе олопатадина гидрохлорида
0,1% (Опатанол).
особенности действия антигистаминных препаратов местного действия, в том числе олопатадина гидрохлорида
0,1% (Опатанол).
References
- Патерсон Р., Грэммер Л.К., Гринберг П.А. Аллергические болезни: диагностика и лечение. Пер. с англ./Под ред. Чучалина А.Г., Гущина И.С., Улумбекова Э.Г., Фасахова Р.С. М., «ГЭОТАР МЕДИЦИНА». 2000, 768 с.
- Майчук Д.Ю., Куренков В.В., Кашникова О.А. В кн. Актуальные вопросы воспалительных заболеваний глаз. М., 2001, с. 232-234.
- Майчук Ю.Ф. Вестник офтальмологии. 2000, № 5, с. 10-14.
- Scadding G., Keith P.K. Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data. Expert Opin Pharmacother. 2008, v. 9, No. 15, p. 2707-2715.
- Aguilar A.J. et al. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0,1% olopatadine hydrochloride versus 0,05% ketotifen fumarate. Acta Ophthalmologica Scandinavica. 2000, v. 78, p. 52-55.
- Artal M.N. et al. A forced choice comfort study of olopatadine hydrochloride 0,1% versus ketotifen fumarate 0,05%. Acta Ophthalmologica Scandinavica. 2000, v. 78, p. 64-65.
- Berdy G.J. et al. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0,1% ophthalmic solution and ketotifen fumarate 0,025% ophthalmic solution in the conjunctival antigen challenge model. Clinical Therapeutics. v. 22, no. 7, p. 1-8.
- Berdy G.J., Stoppel J.O., Epstein A.B. Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0,1% ophthalmic solution and loteprednol etabonate 0,2% ophthalmic suspension in the conjunctival allergen challenge model. Clin. Ther. 2002, v. 24 (6), p. 918-929.
- Bielory L., Lien K.W., Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005, v. 65 (2), p. 215-228.
- Butrus et al. Comparison of the Clinical Efficacy and Comfort of Olopatadine Hydrochloride 0,1% Ophthalmic Solution and Nedocromil Sodium 2% Ophthalmic Solution in the Human Conjunctival Allergen Challenge Model. Reprinted from Clinical Therapeutics. Excerpta Medica Inc. 2000, v. 22, No. 12.
- Katelaris C.H., Ciprandi G., Missotten L., Turner F.D., Bertin D., Berdeaux G., for the International Olopatadine Study Group. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0,1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis. Clin. Ther. 2002, v. 24 (10), p. 1561-1575.
- Lanier B.Q., Gross R.D., Marks B.B., Cockrum P.C., Juniper E.F. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms. Ann. Allergy Asthma Immunol. 2001, v. 86, p. 641-648.
- Leonardi A., Zafirakis P. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: A double-masked, environmental study of patient preference. Curr. Med. Res. Opin. 2004, v. 20 (8), p. 1167-1173.
- Rosenwasser L.J., O'Brien T., Weyne J. Mast cell stabilization and antihistamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research. Curr. Med. Res. Opin. 2005, v. 21 (9), p. 1377-1387.
- Spangler D.L., Bensch G., Berdy G.J. Evaluation of the efficacy of olopatadine hydrochloride 0,1% ophthalmic solution and azelastine hydrochloride 0,05% ophthalmic solution in the conjunctival allergen challenge model. Clinical Therapeutics. 2001, v. 23, p. 1272-1280.
- Майчук Ю.Ф., Позднякова В.В., Якушина Л.Н. Опатанол (олопатадин 0,1%) в лечении аллергических заболеваний глаз. РМЖ, 2007, т. 8, № 2, с. 63-67.
Supplementary files
